270 related articles for article (PubMed ID: 18086506)
21. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.
Vilar L; Oliveira CP; Faintuch J; Mello ES; Nogueira MA; Santos TE; Alves VA; Carrilho FJ
Nutrition; 2008; 24(11-12):1097-102. PubMed ID: 18640006
[TBL] [Abstract][Full Text] [Related]
22. Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men.
Petersson H; Arnlöv J; Zethelius B; Risérus U
Diabetes Res Clin Pract; 2010 Mar; 87(3):379-84. PubMed ID: 20022128
[TBL] [Abstract][Full Text] [Related]
23. Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH).
Capristo E; Miele L; Forgione A; Vero V; Farnetti S; Mingrone G; Greco AV; Gasbarrini G; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):265-8. PubMed ID: 16231587
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.
Videla LA; Rodrigo R; Araya J; Poniachik J
Free Radic Biol Med; 2004 Nov; 37(9):1499-507. PubMed ID: 15454290
[TBL] [Abstract][Full Text] [Related]
25. Dietary intakes of alpha-linolenic and linoleic acids are inversely associated with serum C-reactive protein levels among Japanese men.
Poudel-Tandukar K; Nanri A; Matsushita Y; Sasaki S; Ohta M; Sato M; Mizoue T
Nutr Res; 2009 Jun; 29(6):363-70. PubMed ID: 19628101
[TBL] [Abstract][Full Text] [Related]
26. Bile acid levels are increased in the liver of patients with steatohepatitis.
Aranha MM; Cortez-Pinto H; Costa A; da Silva IB; Camilo ME; de Moura MC; Rodrigues CM
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):519-25. PubMed ID: 18467911
[TBL] [Abstract][Full Text] [Related]
27. [Antioxidant status in nonalcoholic steatohepatitis].
Park KS; Jang BK; Kwon KM; Chung WJ; Cho KB; Hwang JS; Ahn SH; Mun KC; Kim YH
Korean J Hepatol; 2005 Jun; 11(2):135-43. PubMed ID: 15980672
[TBL] [Abstract][Full Text] [Related]
28. Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis.
Musso G; Gambino R; De Michieli F; Biroli G; Fagà E; Pagano G; Cassader M
Ann Med; 2008; 40(5):383-94. PubMed ID: 18484349
[TBL] [Abstract][Full Text] [Related]
29. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M
Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388
[TBL] [Abstract][Full Text] [Related]
30. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
31. Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice.
de Oliveira CP; Stefano JT; de Lima VM; de Sá SV; Simplicio FI; de Mello ES; Corrêa-Giannella ML; Alves VA; Laurindo FR; de Oliveira MG; Giannella-Neto D; Carrilho FJ
J Hepatol; 2006 Nov; 45(5):725-33. PubMed ID: 16935387
[TBL] [Abstract][Full Text] [Related]
32. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
33. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
[TBL] [Abstract][Full Text] [Related]
34. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Younossi ZM
Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
[TBL] [Abstract][Full Text] [Related]
35. The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity.
Valenzuela R; Videla LA
Food Funct; 2011 Nov; 2(11):644-8. PubMed ID: 22008843
[TBL] [Abstract][Full Text] [Related]
36. Liver fat and lipid oxidation in humans.
Kotronen A; Seppälä-Lindroos A; Vehkavaara S; Bergholm R; Frayn KN; Fielding BA; Yki-Järvinen H
Liver Int; 2009 Oct; 29(9):1439-46. PubMed ID: 19602132
[TBL] [Abstract][Full Text] [Related]
37. Metabolic disturbances in non-alcoholic fatty liver disease.
Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
[TBL] [Abstract][Full Text] [Related]
38. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
Tessari P; Coracina A; Cosma A; Tiengo A
Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
[TBL] [Abstract][Full Text] [Related]
39. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women.
Warensjö E; Ohrvall M; Vessby B
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):128-36. PubMed ID: 16487913
[TBL] [Abstract][Full Text] [Related]
40. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder.
Spahis S; Vanasse M; Bélanger SA; Ghadirian P; Grenier E; Levy E
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):47-53. PubMed ID: 18757191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
